To verify the regulatory role of p38 in ABCG2 function, we employed the p38 inhibitor BIRB 796 to assess its impact on the sensitivity of tumor cells to various chemotherapeutic drugs, including MIT, DOX, and TP, all of which are ABCG2 substrates.15 Here, MAPK14 is linked to neoplasm.